BioSpace News Archive

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN) (OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (“CBN”), is pleased to announce, further to its press release dated June 19th, 2020,

GCAR, Eisai and UPMC, on Behalf of REMAP-CAP Investigator Network, Announce Eritoran’s Inclusion in REMAP-COVID, An Adaptive Clinical Trial to Test Interventions for Patients With Moderate and Severe COVID Infection

ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUSⓇ), today announced the 510(k) Premarket Notification submission to the U.S. Food and Drug Administration (“FDA”) for its TAEUS Fatty Liver Imaging Probe (“FLIP”).

Neutra Corp. (OTC PINK:NTRR) is busy moving its administrative offices to its newly opened manufacturing and production site in Katy.

NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today announced that it has been added to the Russell Microcap® Index effective after the U.S. markets opened yesterday, Monday, June 29, 2020.

Medical imaging and AI company Perimeter Medical Imaging AI, Inc. (“Perimeter” or the “Company”) announced that the previously announced reverse take-over of New World Resource Corp. (“New World”) by Perimeter Medical Imaging, Inc. (“Pre-Closing Perimeter”) via plan of arrangement (the “Plan of Arrangement”) has been completed

Mezzion Pharma Co. Ltd. (140410.KQ), announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of udenafil to improve the physiology of patients 12 years of age and older with single ventricle heart disease (SVHD) who have undergone the Fontan operation

Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today new data and a patent filing showing its clinical-stage cancer immunotherapeutic product StemVacs™ appears to reduce innate immune induced inflammation in lungs while stimulating immune cells known to possess antiviral properties.

Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), announce that Pixee Medical, a France-based medical company, in collaboration with Pr. Remy Nizard from Hopital Lariboisière in Paris, France, performed the world’s first Knee+ total knee replacement surgery on June 24th using the Vuzix M400 AR Smart Glasses

During June, Calliditas Therapeutics AB (publ) has issued 9,230,770 common shares as a result of the initial public offering on The Nasdaq Global Select Market in the United States and concurrent private placement of common shares to certain qualified investors in Europe and certain other jurisdictions outside of the United States.